<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33374485</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>24</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>How to Build and to Protect the Neuromuscular Junction: The Role of the Glial Cell Line-Derived Neurotrophic Factor.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22010136</ELocationID><Abstract><AbstractText>The neuromuscular junction (NMJ) is at the crossroad between the nervous system (NS) and the muscle. Following neurotransmitter release from the motor neurons (MNs), muscle contraction occurs and movement is generated. Besides eliciting muscle contraction, the NMJ represents a site of chemical bidirectional interplay between nerve and muscle with the active participation of Schwann cells. Indeed, signals originating from the muscle play an important role in synapse formation, stabilization, maintenance and function, both in development and adulthood. We focus here on the contribution of the Glial cell line-Derived Neurotrophic Factor (GDNF) to these processes and to its potential role in the protection of the NMJ during neurodegeneration. Historically related to the maintenance and survival of dopaminergic neurons of the <i>substantia nigra</i>, GDNF also plays a fundamental role in the peripheral NS (PNS). At this level, it promotes muscle trophism and it participates to the functionality of synapses. Moreover, compared to the other neurotrophic factors, GDNF shows unique peculiarities, which make its contribution essential in neurodegenerative disorders. While describing the known structural and functional changes occurring at the NMJ during neurodegeneration, we highlight the role of GDNF in the NMJ-muscle cross-talk and we review its therapeutic potential in counteracting the degenerative process occurring in the PNS in progressive and severe diseases such as Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). We also describe functional 3D neuromuscular co-culture systems that have been recently developed as a model for studying both NMJ formation in vitro and its involvement in neuromuscular disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stanga</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1454-0713</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Brain Development and Disease, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Neuroscience (INN), 10125 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boido</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1211-1552</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Brain Development and Disease, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Neuroscience (INN), 10125 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kienlen-Campard</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1086-2942</Identifier><AffiliationInfo><Affiliation>Institute of Neuroscience (IoNS), Universit&#xe9; Catholique de Louvain (UCLouvain), 1200 Bruxelles, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>"Dipartimenti di Eccellenza 2018-2022" to the Department of Neuroscience "Rita Levi Montalcini"</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495039">GDNF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051100">Glial Cell Line-Derived Neurotrophic Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051100" MajorTopicYN="N">Glial Cell Line-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="N">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D neuromuscular model</Keyword><Keyword MajorTopicYN="N">AD</Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">GDNF</Keyword><Keyword MajorTopicYN="N">SMA</Keyword><Keyword MajorTopicYN="N">motor neuron diseases</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">neuromuscular junctions</Keyword><Keyword MajorTopicYN="N">neurotrophic factors</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>30</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33374485</ArticleId><ArticleId IdType="pmc">PMC7794999</ArticleId><ArticleId IdType="doi">10.3390/ijms22010136</ArticleId><ArticleId IdType="pii">ijms22010136</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guarino S.R., Canciani A., Forneris F. Dissecting the Extracellular Complexity of Neuromuscular Junction Organizers. Front. Mol. Biosci. 2020;6:156. doi: 10.3389/fmolb.2019.00156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2019.00156</ArticleId><ArticleId IdType="pmc">PMC6966886</ArticleId><ArticleId IdType="pubmed">31998752</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayati A., Berman T. Localized vs. Systematic Neurodegeneration: A Paradigm Shift in Understanding Neurodegenerative Diseases. Front. Syst. Neurosci. 2017;11:62. doi: 10.3389/fnsys.2017.00062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2017.00062</ArticleId><ArticleId IdType="pmc">PMC5572257</ArticleId><ArticleId IdType="pubmed">28878634</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo X., Castro-Obreg&#xf3;n S., Guti&#xe9;rrez-Becker B., Guti&#xe9;rrez-Ospina G., Karalis N., Khalil A.A., Lopez-Noguerola J.S., Rodr&#xed;guez L.L., Mart&#xed;nez-Mart&#xed;nez E., Perez-Cruz C., et al. Re-thinking the Etiological Framework of Neurodegeneration. Front. Neurosci. 2019;13:728. doi: 10.3389/fnins.2019.00728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00728</ArticleId><ArticleId IdType="pmc">PMC6667555</ArticleId><ArticleId IdType="pubmed">31396030</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Sethumadhavan A., Krishnan U.M. Toward Building the Neuromuscular Junction: In Vitro Models to Study Synaptogenesis and Neurodegeneration. ACS Omega. 2019;4:12969&#x2013;12977. doi: 10.1021/acsomega.9b00973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.9b00973</ArticleId><ArticleId IdType="pmc">PMC6682064</ArticleId><ArticleId IdType="pubmed">31460423</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanni C., Stanga S., Racchi M., Govoni S. The expanding universe of neurotrophic factors: Therapeutic potential in aging and age-associated disorders. Curr. Pharm. Des. 2010;16:698&#x2013;717. doi: 10.2174/138161210790883741.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161210790883741</ArticleId><ArticleId IdType="pubmed">20388080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartus R.T., Johnson E.M., Jr. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned? Neurobiol. Dis. 2017;97:156&#x2013;168. doi: 10.1016/j.nbd.2016.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.03.027</ArticleId><ArticleId IdType="pubmed">27063798</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy Y.S., Gilgun-Sherki Y., Melamed E., Offen D. Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases. BioDrugs. 2005;19:97&#x2013;127. doi: 10.2165/00063030-200519020-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00063030-200519020-00003</ArticleId><ArticleId IdType="pubmed">15807629</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller G.B., Barde Y.-A. Signalling through the neurotrophin receptor p75NTR. Curr. Opin. Neurobiol. 1997;7:413&#x2013;418. doi: 10.1016/s0959-4388(97)80071-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-4388(97)80071-2</ArticleId><ArticleId IdType="pubmed">9232808</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamburger V., Levi-Montalcini R. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J. Exp. Zool. 1949;111:457&#x2013;501. doi: 10.1002/jez.1401110308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jez.1401110308</ArticleId><ArticleId IdType="pubmed">18142378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellweg R., Von Richthofen S., Anders D., Baethge C., R&#xf6;pke S., Hartung H.-D., Gericke C.A. The time course of nerve growth factor content in different neuropsychiatric diseases&#x2014;A unifying hypothesis. J. Neural Transm. 1998;105:871&#x2013;903. doi: 10.1007/s007020050100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007020050100</ArticleId><ArticleId IdType="pubmed">9869324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer M., Pagliusi S.R., Hohn A., Leibrock J., Barde Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 1990;9:2459&#x2013;2464. doi: 10.1002/j.1460-2075.1990.tb07423.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1990.tb07423.x</ArticleId><ArticleId IdType="pmc">PMC552273</ArticleId><ArticleId IdType="pubmed">2369898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccato C., Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat. Rev. Neurol. 2009;5:311&#x2013;322. doi: 10.1038/nrneurol.2009.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2009.54</ArticleId><ArticleId IdType="pubmed">19498435</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi K., Jasmin B.J. BDNF Is Expressed in Skeletal Muscle Satellite Cells and Inhibits Myogenic Differentiation. J. Neurosci. 2006;26:5739&#x2013;5749. doi: 10.1523/JNEUROSCI.5398-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5398-05.2006</ArticleId><ArticleId IdType="pmc">PMC6675269</ArticleId><ArticleId IdType="pubmed">16723531</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.O., Flavell R.A. TGF-&#x3b2;: A Master of All T Cell Trades. Cell. 2008;134:392&#x2013;404. doi: 10.1016/j.cell.2008.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.07.025</ArticleId><ArticleId IdType="pmc">PMC3677783</ArticleId><ArticleId IdType="pubmed">18692464</ArticleId></ArticleIdList></Reference><Reference><Citation>Landreth G.E. Growth factors. In: Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., Uhler M.D., editors. Basic Neurochemistry, Molecular, Cellular and Medical Aspects. 6th ed. Lippincott-Raven; Philadelphia, PA, USA: 1999. pp. 384&#x2013;396.</Citation></Reference><Reference><Citation>Horton A.R., Bartlett P.F., Pennica D., Davies A.M. Cytokines promote the survival of mouse cranial sensory neurones at different developmental stages. Eur. J. Neurosci. 1998;10:673&#x2013;679. doi: 10.1046/j.1460-9568.1998.00079.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9568.1998.00079.x</ArticleId><ArticleId IdType="pubmed">9749728</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis R., Adryan K.M., Zhu Y., Harkness P.J., Lindsay R.M., Distefano P.S. Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury. Nat. Cell Biol. 1993;365:253&#x2013;255. doi: 10.1038/365253a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/365253a0</ArticleId><ArticleId IdType="pubmed">8371780</ArticleId></ArticleIdList></Reference><Reference><Citation>Quesada A., Romeo H.E., Micevych P.E. Distribution and localization patterns of estrogen receptor-&#x3b2; and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: Localization of ER&#x3b2; and IGF-1R in substantia nigra. J. Comp. Neurol. 2007;503:198&#x2013;208. doi: 10.1002/cne.21358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.21358</ArticleId><ArticleId IdType="pmc">PMC2907103</ArticleId><ArticleId IdType="pubmed">17480015</ArticleId></ArticleIdList></Reference><Reference><Citation>Runeberg-Roos P., Penn R.D. Improving therapeutic potential of GDNF family ligands. Cell Tissue Res. 2020;382:173&#x2013;183. doi: 10.1007/s00441-020-03256-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-020-03256-z</ArticleId><ArticleId IdType="pmc">PMC7529618</ArticleId><ArticleId IdType="pubmed">32725425</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblad C., Kirik D., Devaux B., Moffat B., Phillips H.S., Bj&#xf6;rklund A. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson&#x2019;s disease after administration into the striatum or the lateral ventricle. Eur. J. Neurosci. 1999;11:1554&#x2013;1566. doi: 10.1046/j.1460-9568.1999.00566.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9568.1999.00566.x</ArticleId><ArticleId IdType="pubmed">10215908</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh R.H., Tansey M.G., Lampe P.A., Fahrner T.J., Enomoto H., Simburger K.S., Leitner M.L., Araki T., Johnson E.M., Milbrandt J. Artemin, a Novel Member of the GDNF Ligand Family, Supports Peripheral and Central Neurons and Signals through the GFR&#x3b1;3&#x2013;RET Receptor Complex. Neuron. 1998;21:1291&#x2013;1302. doi: 10.1016/S0896-6273(00)80649-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80649-2</ArticleId><ArticleId IdType="pubmed">9883723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993;260:1130&#x2013;1132. doi: 10.1126/science.8493557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8493557</ArticleId><ArticleId IdType="pubmed">8493557</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks W.J., Bartus R.T., Siffert J., Davis C.S., Lozano A., Boulis N., Vitek J., Stacy M., Turner D., Verhagen L., et al. Gene delivery of AAV2-neurturin for Parkinson&#x2019;s disease: A double-blind, randomised, controlled trial. Lancet Neurol. 2010;9:1164&#x2013;1172. doi: 10.1016/S1474-4422(10)70254-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70254-4</ArticleId><ArticleId IdType="pubmed">20970382</ArticleId></ArticleIdList></Reference><Reference><Citation>Paratcha G., Ledda F., Baars L., Coulpier M., Besset V., Anders J., Scott R.P., Ib&#xe1;&#xf1;ez C.F. Released GFR&#x3b1;1 Potentiates Downstream Signaling, Neuronal Survival, and Differentiation via a Novel Mechanism of Recruitment of c-Ret to Lipid Rafts. Neuron. 2001;29:171&#x2013;184. doi: 10.1016/S0896-6273(01)00188-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00188-X</ArticleId><ArticleId IdType="pubmed">11182089</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudet C., Ernfors P. Soluble and bound forms of GFR?1 elicit different GDNF-independent neurite growth responses in primary sensory neurons. Dev. Dyn. 2003;227:27&#x2013;34. doi: 10.1002/dvdy.10280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.10280</ArticleId><ArticleId IdType="pubmed">12701096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. Structural studies of GDNF family ligands with their receptors&#x2014;Insights into ligand recognition and activation of receptor tyrosine kinase RET. Biochim. Biophys. Acta (BBA) 2013;1834:2205&#x2013;2212. doi: 10.1016/j.bbapap.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2012.10.008</ArticleId><ArticleId IdType="pubmed">23085183</ArticleId></ArticleIdList></Reference><Reference><Citation>Paratcha G., Ledda F., Ib&#xe1;&#xf1;ez C.F. The Neural Cell Adhesion Molecule NCAM Is an Alternative Signaling Receptor for GDNF Family Ligands. Cell. 2003;113:867&#x2013;879. doi: 10.1016/S0092-8674(03)00435-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(03)00435-5</ArticleId><ArticleId IdType="pubmed">12837245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bespalov M.M., Sidorova Y.A., Tumova S., Ahonen-Bishopp A., Magalh&#xe3;es A.C., Kulesskiy E., Paveliev M., Rivera C., Rauvala H., Saarma M. Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J. Cell Biol. 2011;192:153&#x2013;169. doi: 10.1083/jcb.201009136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201009136</ArticleId><ArticleId IdType="pmc">PMC3019558</ArticleId><ArticleId IdType="pubmed">21200028</ArticleId></ArticleIdList></Reference><Reference><Citation>Springer J., Mu X., Bergmann L., Trojanowski J. Expression of GDNF mRNA in Rat and Human Nervous Tissue. Exp. Neurol. 1994;127:167&#x2013;170. doi: 10.1006/exnr.1994.1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1994.1091</ArticleId><ArticleId IdType="pubmed">8033959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s D., Robledo-Arratia Y., Hern&#xe1;ndez-Mart&#xed;nez R., Escobedo-&#xc1;vila I., Bargas J., Velasco I. Transgenic GDNF Positively Influences Proliferation, Differentiation, Maturation and Survival of Motor Neurons Produced from Mouse Embryonic Stem Cells. Front. Cell. Neurosci. 2016;10:217. doi: 10.3389/fncel.2016.00217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00217</ArticleId><ArticleId IdType="pmc">PMC5018488</ArticleId><ArticleId IdType="pubmed">27672361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmich H.L., Kos L., Cho E.S., Mahon K.A., Zimmer A. Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech. Dev. 1996;54:95&#x2013;105. doi: 10.1016/0925-4773(95)00464-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0925-4773(95)00464-5</ArticleId><ArticleId IdType="pubmed">8808409</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Guo H., Hellard D., Katz D. Glial cell line-derived neurotrophic factor (GDNF) is required for differentiation of pontine noradrenergic neurons and patterning of central respiratory output. Neuroscience. 2005;130:95&#x2013;105. doi: 10.1016/j.neuroscience.2004.08.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.08.036</ArticleId><ArticleId IdType="pubmed">15561428</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo T.F., Ries V., Cho J., Kholodilov N., Burke R.E. Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat. J. Comp. Neurol. 2005;484:57&#x2013;67. doi: 10.1002/cne.20463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20463</ArticleId><ArticleId IdType="pmc">PMC3092474</ArticleId><ArticleId IdType="pubmed">15717300</ArticleId></ArticleIdList></Reference><Reference><Citation>Buss R.R., Gould T.W., Ma J., Vinsant S., Prevette D., Winseck A., Toops K.A., Hammarback J.A., Smith T.L., Oppenheim R.W. Neuromuscular Development in the Absence of Programmed Cell Death: Phenotypic Alteration of Motoneurons and Muscle. J. Neurosci. 2006;26:13413&#x2013;13427. doi: 10.1523/JNEUROSCI.3528-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3528-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674711</ArticleId><ArticleId IdType="pubmed">17192424</ArticleId></ArticleIdList></Reference><Reference><Citation>Saavedra A., Baltazar G., Duarte E.P. Driving GDNF expression: The green and the red traffic lights. Prog. Neurobiol. 2008;86:186&#x2013;215. doi: 10.1016/j.pneurobio.2008.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.09.006</ArticleId><ArticleId IdType="pubmed">18824211</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotoyama H., Iwakura Y., Oda K., Sasaoka T., Takei N., Kakita A., Enomoto H., Nawa H. Striatal hypodopamine phenotypes found in transgenic mice that overexpress glial cell line-derived neurotrophic factor. Neurosci. Lett. 2017;654:99&#x2013;106. doi: 10.1016/j.neulet.2017.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.005</ArticleId><ArticleId IdType="pubmed">28645787</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozas E., Ib&#xe1;&#xf1;ez C.F. GDNF and GFR&#x3b1;1 Promote Differentiation and Tangential Migration of Cortical GABAergic Neurons. Neuron. 2005;45:701&#x2013;713. doi: 10.1016/j.neuron.2005.01.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.01.043</ArticleId><ArticleId IdType="pubmed">15748846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernsberger U. The role of GDNF family ligand signalling in the differentiation of sympathetic and dorsal root ganglion neurons. Cell Tissue Res. 2008;333:353&#x2013;371. doi: 10.1007/s00441-008-0634-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-008-0634-4</ArticleId><ArticleId IdType="pmc">PMC2516536</ArticleId><ArticleId IdType="pubmed">18629541</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;r K.J., Saldanha G.J.F., Kennedy A.J., Facer P., Birch R., Carlstedt T., Anand P. GDNF and its receptor component Ret in injured human nerves and dorsal root ganglia. Neuroreport. 1998;9:43&#x2013;47. doi: 10.1097/00001756-199801050-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199801050-00009</ArticleId><ArticleId IdType="pubmed">9592045</ArticleId></ArticleIdList></Reference><Reference><Citation>Trupp M., Ryd&#xe9;n M., J&#xf6;rnvall H., Funakoshi H., Timmusk T., Arenas E., Ib&#xe1;&#xf1;ez C.F. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 1995;130:137&#x2013;148. doi: 10.1083/jcb.130.1.137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.130.1.137</ArticleId><ArticleId IdType="pmc">PMC2120511</ArticleId><ArticleId IdType="pubmed">7790368</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Hase A., Miyata Y., Arahata K., Akazawa C. Prominent expression of glial cell line-derived neurotrophic factor in human skeletal muscle. J Comp. Neurol. 1998;402:303&#x2013;312. doi: 10.1002/(SICI)1096-9861(19981221)402:3&lt;303::AID-CNE2&gt;3.0.CO;2-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19981221)402:3&lt;303::AID-CNE2&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">9853901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano M., Suzuki H. Quantitative analyses of expression of GDNF and neurotrophins during postnatal development in rat skeletal muscles. Neurosci. Res. 2003;45:391&#x2013;399. doi: 10.1016/S0168-0102(03)00010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-0102(03)00010-5</ArticleId><ArticleId IdType="pubmed">12657452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahavi E.E., Ionescu A., Gluska S., Gradus T., Ben-Yaakov K., Perlson E. A compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functions. J. Cell Sci. 2015;128:1241&#x2013;1252. doi: 10.1242/jcs.167544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.167544</ArticleId><ArticleId IdType="pmc">PMC4359927</ArticleId><ArticleId IdType="pubmed">25632161</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos D., Giudetti G., Micera S., Navarro X., Del Valle J. Focal release of neurotrophic factors by biodegradable microspheres enhance motor and sensory axonal regeneration in vitro and in vivo. Brain Res. 2016;1636:93&#x2013;106. doi: 10.1016/j.brainres.2016.01.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.01.051</ArticleId><ArticleId IdType="pubmed">26854135</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing M., Zhuang H., Bu S., Hua L., Darabi M.A., Cao X. Gelatin-methacrylamide gel loaded with microspheres to deliver GDNF in bilayer collagen conduit promoting sciatic nerve growth. Int. J. Nanomed. 2016;11:1383&#x2013;1394. doi: 10.2147/IJN.S96324.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S96324</ArticleId><ArticleId IdType="pmc">PMC4824364</ArticleId><ArticleId IdType="pubmed">27099497</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;ke A., Gordon T., Zochodne D., Sulaiman O. A Decline in Glial Cell-Line-Derived Neurotrophic Factor Expression Is Associated with Impaired Regeneration after Long-Term Schwann Cell Denervation. Exp. Neurol. 2002;173:77&#x2013;85. doi: 10.1006/exnr.2001.7826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2001.7826</ArticleId><ArticleId IdType="pubmed">11771940</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker M.J., Xu X.-M. History of Glial Cell Line-Derived Neurotrophic Factor (GDNF) and Its Use for Spinal Cord Injury Repair. Brain Sci. 2018;8:109. doi: 10.3390/brainsci8060109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci8060109</ArticleId><ArticleId IdType="pmc">PMC6025482</ArticleId><ArticleId IdType="pubmed">29899247</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo M.D., Sander S., Tenenbaum L. GDNF, A Neuron-Derived Factor Upregulated in Glial Cells during Disease. J. Clin. Med. 2020;9:456. doi: 10.3390/jcm9020456.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020456</ArticleId><ArticleId IdType="pmc">PMC7073520</ArticleId><ArticleId IdType="pubmed">32046031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudet C., Pozas E., Adameyko I., Andersson E., Ericson J., Ernfors P. Retrograde Signaling onto Ret during Motor Nerve Terminal Maturation. J. Neurosci. 2008;28:963&#x2013;975. doi: 10.1523/JNEUROSCI.4489-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4489-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671002</ArticleId><ArticleId IdType="pubmed">18216204</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.-F.H., Li L., Lo A.C., Newsome A.L., Prevette D.M., Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nat. Cell Biol. 1995;373:344&#x2013;346. doi: 10.1038/373344a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/373344a0</ArticleId><ArticleId IdType="pubmed">7830769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Gupta A., Toledo-Rodriguez M., Wu C.Z., Markram H. Anatomical, Physiological, Molecular and Circuit Properties of Nest Basket Cells in the Developing Somatosensory Cortex. Cereb. Cortex. 2002;12:395&#x2013;410. doi: 10.1093/cercor/12.4.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/12.4.395</ArticleId><ArticleId IdType="pubmed">11884355</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Q.T., Parsadanian A.S., Snider W.D., Lichtman J.W. Hyperinnervation of Neuromuscular Junctions Caused by GDNF Overexpression in Muscle. Science. 1998;279:1725&#x2013;1729. doi: 10.1126/science.279.5357.1725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.279.5357.1725</ArticleId><ArticleId IdType="pubmed">9497292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.-Y., Yang F., He X.-P., Je H.S., Zhou J.-Z., Eckermann K., Kawamura D., Feng L., Shen L., Lu B. Regulation of Neuromuscular Synapse Development by Glial Cell Line-derived Neurotrophic Factor and Neurturin. J. Biol. Chem. 2002;277:10614&#x2013;10625. doi: 10.1074/jbc.M106116200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M106116200</ArticleId><ArticleId IdType="pubmed">11790765</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S., Zanou N., Audouard E., Tasiaux B., Contino S., Vandermeulen G., Ren&#xe9; F., Loeffler J., Clotman F., Gailly P., et al. APP-dependent glial cell line-derived neurotrophic factor gene expression drives neuromuscular junction formation. FASEB J. 2015;30:1696&#x2013;1711. doi: 10.1096/fj.15-278739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.15-278739</ArticleId><ArticleId IdType="pubmed">26718890</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller-Peck C.R., Feng G., Sanes J.R., Yan Q., Lichtman J.W., Snider W.D. Glial Cell Line-Derived Neurotrophic Factor Administration in Postnatal Life Results in Motor Unit Enlargement and Continuous Synaptic Remodeling at the Neuromuscular Junction. J. Neurosci. 2001;21:6136&#x2013;6146. doi: 10.1523/JNEUROSCI.21-16-06136.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-16-06136.2001</ArticleId><ArticleId IdType="pmc">PMC6763186</ArticleId><ArticleId IdType="pubmed">11487637</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwick M., Teng L., Mu X., Springer J.E., Davis B.M. Overexpression of GDNF Induces and Maintains Hyperinnervation of Muscle Fibers and Multiple End-Plate Formation. Exp. Neurol. 2001;171:342&#x2013;350. doi: 10.1006/exnr.2001.7753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2001.7753</ArticleId><ArticleId IdType="pubmed">11573987</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrwein E.A., Roskelley E.M., Spitsbergen J.M. GDNF is regulated in an activity-dependent manner in rat skeletal muscle. Muscle Nerve. 2002;26:206&#x2013;211. doi: 10.1002/mus.10179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10179</ArticleId><ArticleId IdType="pubmed">12210384</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough M.B., Domire Z.J., Reed A.M., Amin S., Ytterberg S.R., Chen Q., An K.-N. Evaluation of muscles affected by myositis using magnetic resonance elastography. Muscle Nerve. 2011;43:585&#x2013;590. doi: 10.1002/mus.21923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21923</ArticleId><ArticleId IdType="pmc">PMC3059125</ArticleId><ArticleId IdType="pubmed">21319167</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyorkos A.M., Spitsbergen J.M. GDNF content and NMJ morphology are altered in recruited muscles following high-speed and resistance wheel training. Physiol. Rep. 2014;2:e00235. doi: 10.1002/phy2.235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phy2.235</ArticleId><ArticleId IdType="pmc">PMC3966253</ArticleId><ArticleId IdType="pubmed">24744904</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S., Caretto A., Boido M., Vercelli A. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. Int. J. Mol. Sci. 2020;21:3719. doi: 10.3390/ijms21103719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103719</ArticleId><ArticleId IdType="pmc">PMC7279270</ArticleId><ArticleId IdType="pubmed">32466216</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J., Liu X., Wu Q., Zhou M., Zhang Y., Mazhar M., Huang X., Wang L., He F. Hippo/YAP Pathway Plays a Critical Role in Effect of GDNF Against A&#x3b2;-Induced Inflammation in Microglial Cells. DNA Cell Biol. 2020;39:1064&#x2013;1071. doi: 10.1089/dna.2019.5308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2019.5308</ArticleId><ArticleId IdType="pubmed">32255663</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;yh&#xf6;nen S., Er S., Domanskyi A., Airavaara M. Effects of Neurotrophic Factors in Glial Cells in the Central Nervous System: Expression and Properties in Neurodegeneration and Injury. Front. Physiol. 2019;10:486. doi: 10.3389/fphys.2019.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6499070</ArticleId><ArticleId IdType="pubmed">31105589</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.Y., Liu Y., Tennert C., Sugiura Y., Karakatsani A., Kr&#xf6;ger S., Johnson E.B., Hammer R.E., Lin W., Herz J. APP interacts with LRP4 and agrin to coordinate the development of the neuromuscular junction in mice. eLife. 2013;2:e00220. doi: 10.7554/eLife.00220.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00220</ArticleId><ArticleId IdType="pmc">PMC3748711</ArticleId><ArticleId IdType="pubmed">23986861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M., Xiong W.-C., Mei L. Neuromuscular Junction Formation, Aging, and Disorders. Annu. Rev. Physiol. 2018;80:159&#x2013;188. doi: 10.1146/annurev-physiol-022516-034255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034255</ArticleId><ArticleId IdType="pubmed">29195055</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nat. Cell Biol. 1998;391:387&#x2013;390. doi: 10.1038/34910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/34910</ArticleId><ArticleId IdType="pubmed">9450754</ArticleId></ArticleIdList></Reference><Reference><Citation>Hage S., Marinangeli C., Stanga S., Octave J.-N., Quetin-Leclercq J., Kienlen-Campard P. Gamma-Secretase Inhibitor Activity of a Pterocarpus erinaceus Extract. Neurodegener. Dis. 2014;14:39&#x2013;51. doi: 10.1159/000355557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000355557</ArticleId><ArticleId IdType="pubmed">24192706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hage S., Stanga S., Marinangeli C., Octave J.-N., Dewachter I., Quetin-Leclercq J., Kienlen-Campard P. Characterization of Pterocarpus erinaceus kino extract and its gamma-secretase inhibitory properties. J. Ethnopharmacol. 2015;163:192&#x2013;202. doi: 10.1016/j.jep.2015.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2015.01.028</ArticleId><ArticleId IdType="pubmed">25639816</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S., Vrancx C., Tasiaux B., Marinangeli C., Karlstr&#xf6;m H., Kienlen-Campard P. Specificity of presenilin-1- and presenilin-2-dependent &#x3b3;-secretases towards substrate processing. J. Cell. Mol. Med. 2017;22:823&#x2013;833. doi: 10.1111/jcmm.13364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13364</ArticleId><ArticleId IdType="pmc">PMC5783875</ArticleId><ArticleId IdType="pubmed">28994238</ArticleId></ArticleIdList></Reference><Reference><Citation>Contino S., Porporato P.E., Bird M., Marinangeli C., Opsomer R., Sonveaux P., Bontemps F., Dewachter I., Octave J.-N., Bertrand L., et al. Presenilin 2-Dependent Maintenance of Mitochondrial Oxidative Capacity and Morphology. Front. Physiol. 2017;8:796. doi: 10.3389/fphys.2017.00796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00796</ArticleId><ArticleId IdType="pmc">PMC5650731</ArticleId><ArticleId IdType="pubmed">29085303</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Berg L.H.V.D., Kiernan M.C. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:639&#x2013;649. doi: 10.1038/nrneurol.2011.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb S.J., Kissel J.T. Spinal Muscular Atrophy. Neurol. Clin. 2015;33:831&#x2013;846. doi: 10.1016/j.ncl.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.004</ArticleId><ArticleId IdType="pmc">PMC4628728</ArticleId><ArticleId IdType="pubmed">26515624</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M., McHugh J., Tork C., Shelley B., Hayes A., Bellantuono I., Aebischer P., Svendsen C.N. Direct Muscle Delivery of GDNF With Human Mesenchymal Stem Cells Improves Motor Neuron Survival and Function in a Rat Model of Familial ALS. Mol. Ther. 2008;16:2002&#x2013;2010. doi: 10.1038/mt.2008.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2008.197</ArticleId><ArticleId IdType="pmc">PMC2678899</ArticleId><ArticleId IdType="pubmed">18797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri M.H., Figlewicz D.A., Bohn M.C. Intramuscular Grafts of Myoblasts Genetically Modified to Secrete Glial Cell Line-Derived Neurotrophic Factor Prevent Motoneuron Loss and Disease Progression in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. Hum. Gene Ther. 1999;10:1853&#x2013;1866. doi: 10.1089/10430349950017536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/10430349950017536</ArticleId><ArticleId IdType="pubmed">10446925</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen G.M., Alkaslasi M., Vit J.-P., Lawless G., Godoy M., Gowing G., Shelest O., Svendsen C.N. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects. Gene Ther. 2017;24:245&#x2013;252. doi: 10.1038/gt.2017.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2017.9</ArticleId><ArticleId IdType="pmc">PMC5404206</ArticleId><ArticleId IdType="pubmed">28276446</ArticleId></ArticleIdList></Reference><Reference><Citation>Koistinen H., Prinjha R., Soden P., Harper A., Banner S.J., Dingwall C., Pradat P.-F., Loeffler J.-P. Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease. Muscle Nerve. 2006;34:444&#x2013;450. doi: 10.1002/mus.20612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20612</ArticleId><ArticleId IdType="pubmed">16856153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryson J.B., Hobbs C., Parsons M.J., Bosch K.D., Pandraud A., Walsh F.S., Doherty P., Greensmith L. Amyloid precursor protein (APP) contributes to pathology in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3871&#x2013;3882. doi: 10.1093/hmg/dds215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds215</ArticleId><ArticleId IdType="pubmed">22678056</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S., Brambilla L., Tasiaux B., Dang A.H., Ivanoiu A., Octave J.-N., Rossi D., Van Pesch V., Kienlen-Campard P. A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology. Front. Neurol. 2018;9:384. doi: 10.3389/fneur.2018.00384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00384</ArticleId><ArticleId IdType="pmc">PMC5988896</ArticleId><ArticleId IdType="pubmed">29899726</ArticleId></ArticleIdList></Reference><Reference><Citation>Menduti G., Ras&#xe0; D.M., Stanga S., Boido M. Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment. Front. Pharmacol. 2020;11:592234. doi: 10.3389/fphar.2020.592234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.592234</ArticleId><ArticleId IdType="pmc">PMC7689316</ArticleId><ArticleId IdType="pubmed">33281605</ArticleId></ArticleIdList></Reference><Reference><Citation>Boido M., Vercelli A. Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy. Front. Neuroanat. 2016;10:6. doi: 10.3389/fnana.2016.00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2016.00006</ArticleId><ArticleId IdType="pmc">PMC4737916</ArticleId><ArticleId IdType="pubmed">26869891</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller N., Shi H., Zelikovich A.S., Ma Y.-C. Motor neuron mitochondrial dysfunction in spinal muscular atrophy. Hum. Mol. Genet. 2016;25:3395&#x2013;3406. doi: 10.1093/hmg/ddw262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw262</ArticleId><ArticleId IdType="pmc">PMC5179954</ArticleId><ArticleId IdType="pubmed">27488123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuentes-Diaz C., Nicole S., Velasco M.E., Borra-Cebrian C., Panozzo C., Frugier T., Millet G., Roblot N., Joshi V., Melki J. Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum. Mol. Genet. 2002;11:1439&#x2013;1447. doi: 10.1093/hmg/11.12.1439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.12.1439</ArticleId><ArticleId IdType="pubmed">12023986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kariya S., Park G.-H., Maeno-Hikichi Y., Leykekhman O., Lutz C., Arkovitz M.S., Landmesser L.T., Monani U.R. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 2008;17:2552&#x2013;2569. doi: 10.1093/hmg/ddn156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn156</ArticleId><ArticleId IdType="pmc">PMC2722888</ArticleId><ArticleId IdType="pubmed">18492800</ArticleId></ArticleIdList></Reference><Reference><Citation>Valsecchi V., Boido M., De Amicis E., Piras A., Vercelli A. Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model. PLoS ONE. 2015;10:e0128560. doi: 10.1371/journal.pone.0128560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128560</ArticleId><ArticleId IdType="pmc">PMC4450876</ArticleId><ArticleId IdType="pubmed">26030275</ArticleId></ArticleIdList></Reference><Reference><Citation>McGovern V.L., Gavrilina T.O., Beattie C.E., Burghes A.H. Embryonic motor axon development in the severe SMA mouse. Hum. Mol. Genet. 2008;17:2900&#x2013;2909. doi: 10.1093/hmg/ddn189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn189</ArticleId><ArticleId IdType="pmc">PMC2722893</ArticleId><ArticleId IdType="pubmed">18603534</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray L.M., Comley L.H., Thomson D., Parkinson N., Talbot K., Gillingwater T.H. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 2007;17:949&#x2013;962. doi: 10.1093/hmg/ddm367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm367</ArticleId><ArticleId IdType="pubmed">18065780</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Benito L., Ruiz R., Tabares L. Synaptic defects in spinal muscular atrophy animal models. Dev. Neurobiol. 2012;72:126&#x2013;133. doi: 10.1002/dneu.20912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.20912</ArticleId><ArticleId IdType="pubmed">21567981</ArticleId></ArticleIdList></Reference><Reference><Citation>McGivern J.V., Patitucci T.N., Nord J.A., Barabas M.-E.A., Stucky C.L., Ebert A.D. Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia. 2013;61:1418&#x2013;1428. doi: 10.1002/glia.22522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22522</ArticleId><ArticleId IdType="pmc">PMC3941074</ArticleId><ArticleId IdType="pubmed">23839956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaretti A., Leoni C., Barone G., Genovese O., Brahe C., Mariotti P., Conti G. Increased Levels of Glial Cell-Derived Neurotrophic Factor in CSF of Infants With SMA. Pediatr. Neurol. 2009;41:195&#x2013;199. doi: 10.1016/j.pediatrneurol.2009.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2009.04.001</ArticleId><ArticleId IdType="pubmed">19664536</ArticleId></ArticleIdList></Reference><Reference><Citation>Audouard E., Schakman O., Ren&#xe9; F., Huettl R.-E., Huber A.B., Loeffler J.-P., Gailly P., Clotman F. The Onecut Transcription Factor HNF-6 Regulates in Motor Neurons the Formation of the Neuromuscular Junctions. PLoS ONE. 2012;7:e50509. doi: 10.1371/journal.pone.0050509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0050509</ArticleId><ArticleId IdType="pmc">PMC3515622</ArticleId><ArticleId IdType="pubmed">23227180</ArticleId></ArticleIdList></Reference><Reference><Citation>Patr&#xf3;n L.A., August P.R. Modeling neuromuscular junctions in vitro: A review of the current progress employing human induced pluripotent stem cells. AIMS Cell Tissue Eng. 2017;2:91&#x2013;118. doi: 10.3934/celltissue.2018.2.91.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/celltissue.2018.2.91</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakooshli M.A., Lippmann E.S., Mulcahy B., Iyer N., Nguyen C.T., Tung K., Stewart B.A., van den Dorpel H., Fuehrmann T., Shoichet M., et al. A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction. eLife. 2019;8:e44530. doi: 10.7554/eLife.44530.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.44530</ArticleId><ArticleId IdType="pmc">PMC6516829</ArticleId><ArticleId IdType="pubmed">31084710</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T., Uzel S.G.M., Kamm R. On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease. Nat. Protoc. 2020;15:421&#x2013;449. doi: 10.1038/s41596-019-0248-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-019-0248-1</ArticleId><ArticleId IdType="pubmed">31932771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanni C., Racchi M., Stanga S., Mazzini G., Ranzenigo A., Polotti R., Memo M., Govoni S., Uberti D. Unfolded p53 in Blood as a Predictive Signature Signature of the Transition from Mild Cognitive Impairment to Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2010;20:97&#x2013;104. doi: 10.3233/JAD-2010-1347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1347</ArticleId><ArticleId IdType="pubmed">20164600</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S., Lanni C., Govoni S., Uberti D., D&#x2019;Orazi G., Racchi M. Unfolded p53 in the pathogenesis of Alzheimer&#x2019;s disease: Is HIPK2 the link? Aging. 2010;2:545&#x2013;554. doi: 10.18632/aging.100205.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100205</ArticleId><ArticleId IdType="pmc">PMC2984604</ArticleId><ArticleId IdType="pubmed">20876941</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S., Lanni C., Sinforiani E., Mazzini G., Racchi M. Searching for Predictive Blood Biomarkers: Misfolded p53 In Mild Cognitive Impairment. Curr. Alzheimer Res. 2012;9:1191&#x2013;1197. doi: 10.2174/156720512804142886.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720512804142886</ArticleId><ArticleId IdType="pubmed">22746246</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers M.J., Rainero I., Vercelli A.E., Aumayr G., De Rosario H., M&#xf6;nter M., Kawashima R., Caglio M., Carbone C., Rubino E., et al. The My Active and Healthy Aging (My-AHA) ICT platform to detect and prevent frailty in older adults: Randomized control trial design and protocol. Alzheimer&#x2019;s Dementia: Transl. Res. Clin. Interv. 2018;4:252&#x2013;262. doi: 10.1016/j.trci.2018.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2018.06.004</ArticleId><ArticleId IdType="pmc">PMC6076210</ArticleId><ArticleId IdType="pubmed">30094329</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>